This case describes a middle-aged man with anti-dipeptidyl-peptidase-like protein 6 (DPPX) encephalitis who exhibited the triad of memory loss, diarrhea, and tremor. The progression of his disease resembled neurodegenerative disease, and his first presentation at our department was 2 years after ...
Protein biochemistry has identified dipeptidyl peptidase-like protein 6 (DPP6) as an auxiliary subunit of Kv4-based A-type channels and thus a potentially important regulator of neuronal excitability. In this study, we used an RNA interference (RNAi) strategy to examine the role DPP6 plays in ...
Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs. The most prevalent form of diabetes is non-insulin-dependent or Type 2 diabetes. Innovative strategies to enhance insulin secretion and thereby improve glu... Rolf...
Anti-Dipeptidyl-peptidase 3Antibody Anti-Dipeptidyl-peptidase 3 Antibody的详细介绍 Target Function:Involved in autophagic vesicle formation. Conjugation with ATG12, through a ubiquitin-like conjugating system involving ATG7 as an E1-like activating enzyme and ATG10 as an E2-like conjugating enzyme, is...
中文名称:Recombinant Human Dipeptidyl-Peptidase 4英文名称:Recombinant Human Dipeptidyl-Peptidase 4 产品类别:重组蛋白 中文名称 【DPP4】重组人二肽基肽酶4 英文名字 Recombinant Human Dipeptidyl-Peptidase 4 供应商 ProSpec 产品货号 ENZ-375 产品报价
A rare autoimmune encephalitis-due to dipeptidyl-peptidase-like protein-6 (DPPX) autoantibody; a case report_html_urlhttp://www.neurology.org/content/82/10_Supplement/P5.169.abstractS., SucheckiL., RisleyE., ZimmermanE., MolhoE., Hanspal...
Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity Glucagon-like peptide 1 (GLP-1) has great potential in diabetes therapy due to its glucose-dependent stimulation of insulin secretion, but this is limited .....
2. Drucker DJ, Nauck MA.: The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet... MA Nauck,RE Ratner,C Kapitza,... - 《Diabetes Care》 被引量: 268发表: 2009年 Dipeptidyl peptidase-4 inhibitors for the treatment of...
We investigated whether structurally different sodium–glucose cotransporter (SGLT) 2 inhibitors, when co-administered with dipeptidyl peptidase-4 (DPP4) inhibitors, could enhance glucagon-like peptide-1 (GLP-1) secretion during oral glucose tolerance tests (OGTTs) in rodents. Three different SGLT inhi...
Dipeptidyl peptidase IV inhibitors as the new treatment for this disease appears to be more promising. 二肽基肽酶Ⅳ抑制剂作为新型抗糖尿病药物越来越引起人们关注。 更多例句>> 3) Dipeptidyl peptidase-Ⅳ inhibitors 二肽酶-Ⅳ抑制剂4) Dipeptidyl peptidase Ⅳ 二肽基肽酶Ⅳ 1. Design,synthesis and...